Nicotine - Effects of Messaging: Difference between revisions

Safer nicotine wiki Tobacco Harm Reduction
Jump to navigation Jump to search
created page
 
Adding content
Line 5: Line 5:
<br>
<br>
=Positive Outcomes=
=Positive Outcomes=
===2024: [https://academic.oup.com/ntr/advance-article/doi/10.1093/ntr/ntae297/7921069 Harnessing hope and bolstering knowledge of how to quit: a qualitative investigation of including efficacy content in tobacco risk communication via daily SMS]===
*"By contrast, messages that address efficacy beliefs can increase hope, knowledge of cessation supports and motivation, thus supporting adaptive responses to smoking health risks."
*Full text in PDF.
**Citation: Lillian Brinken, Kate Shiells, Stuart G Ferguson, Stefania Franja, Anna Blackwell, Claire Braboszcz, Olivia M Maynard, Harnessing hope and bolstering knowledge of how to quit: a qualitative investigation of including efficacy content in tobacco risk communication via daily SMS, Nicotine & Tobacco Research, 2024;, ntae297, https://doi.org/10.1093/ntr/ntae297
***Acknowledgement: This study was supported by an ESRC New Investigator‘s Award, awarded to Dr Olivia Maynard (ES/R003424/1) and Medical Research Council Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/7). Stuart Ferguson has provided expert advice to various pharmaceutical companies and has received researcher-initiated project grant funding (through the GRAND initiative) and travel funds from Pfizer. These companies are not involved in the current study. All other project team members report no conflicts of interest.


=Unintended Consequences=
=Unintended Consequences=
===2024: [https://academic.oup.com/ntr/advance-article/doi/10.1093/ntr/ntae297/7921069 Harnessing hope and bolstering knowledge of how to quit: a qualitative investigation of including efficacy content in tobacco risk communication via daily SMS]===
*"Participants in the present study described how GHWLs [graphic health warning labels] were experienced as stigmatising in the context of broader policies leading to denormalisation of smoking. They felt smokingrelated stigma negatively impacted their motivation to quit and confidence to do so. In light of these and other similar findings35,37, we suggest policies intended to promote denormalisation be re-considered."
*Full text in PDF.
**Citation: Lillian Brinken, Kate Shiells, Stuart G Ferguson, Stefania Franja, Anna Blackwell, Claire Braboszcz, Olivia M Maynard, Harnessing hope and bolstering knowledge of how to quit: a qualitative investigation of including efficacy content in tobacco risk communication via daily SMS, Nicotine & Tobacco Research, 2024;, ntae297, https://doi.org/10.1093/ntr/ntae297
***Acknowledgement: This study was supported by an ESRC New Investigator‘s Award, awarded to Dr Olivia Maynard (ES/R003424/1) and Medical Research Council Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/7). Stuart Ferguson has provided expert advice to various pharmaceutical companies and has received researcher-initiated project grant funding (through the GRAND initiative) and travel funds from Pfizer. These companies are not involved in the current study. All other project team members report no conflicts of interest.

Revision as of 19:20, 29 December 2024





Positive Outcomes

  • "By contrast, messages that address efficacy beliefs can increase hope, knowledge of cessation supports and motivation, thus supporting adaptive responses to smoking health risks."
  • Full text in PDF.
    • Citation: Lillian Brinken, Kate Shiells, Stuart G Ferguson, Stefania Franja, Anna Blackwell, Claire Braboszcz, Olivia M Maynard, Harnessing hope and bolstering knowledge of how to quit: a qualitative investigation of including efficacy content in tobacco risk communication via daily SMS, Nicotine & Tobacco Research, 2024;, ntae297, https://doi.org/10.1093/ntr/ntae297
      • Acknowledgement: This study was supported by an ESRC New Investigator‘s Award, awarded to Dr Olivia Maynard (ES/R003424/1) and Medical Research Council Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/7). Stuart Ferguson has provided expert advice to various pharmaceutical companies and has received researcher-initiated project grant funding (through the GRAND initiative) and travel funds from Pfizer. These companies are not involved in the current study. All other project team members report no conflicts of interest.

Unintended Consequences

  • "Participants in the present study described how GHWLs [graphic health warning labels] were experienced as stigmatising in the context of broader policies leading to denormalisation of smoking. They felt smokingrelated stigma negatively impacted their motivation to quit and confidence to do so. In light of these and other similar findings35,37, we suggest policies intended to promote denormalisation be re-considered."
  • Full text in PDF.
    • Citation: Lillian Brinken, Kate Shiells, Stuart G Ferguson, Stefania Franja, Anna Blackwell, Claire Braboszcz, Olivia M Maynard, Harnessing hope and bolstering knowledge of how to quit: a qualitative investigation of including efficacy content in tobacco risk communication via daily SMS, Nicotine & Tobacco Research, 2024;, ntae297, https://doi.org/10.1093/ntr/ntae297
      • Acknowledgement: This study was supported by an ESRC New Investigator‘s Award, awarded to Dr Olivia Maynard (ES/R003424/1) and Medical Research Council Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/7). Stuart Ferguson has provided expert advice to various pharmaceutical companies and has received researcher-initiated project grant funding (through the GRAND initiative) and travel funds from Pfizer. These companies are not involved in the current study. All other project team members report no conflicts of interest.